DiagnosTear files FDA pre-submission for TeaRx red eye test
DiagnosTear Technologies says it has submitted a pre-submission request to the U.S. Food and Drug Administration for TeaRx(TM), its red eye diagnostic test.
Vancouver, British Columbia--(. - September 3, 2026) - DiagnosTear Technologies Inc.
CSE:DTR (FSE: X8F) ("DiagnosTear" or the "Company"), a developer of innovative point-of-care eye diagnostic solutions, is pleased to announce the submission of a pre-submission request to the U.S.
Food…